Anika Therapeutics (NASDAQ:ANIK) will release its quarterly earnings report on Thursday, 2024-10-31. Here’s a brief overview for investors ahead of the announcement. Analysts anticipate Anika Therapeutics to report an earnings per share (EPS) of $-0.01. Anticipation surrounds Anika Therapeutics’s announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter. New investors should understand that while earnings performance is important, market reactions are often driven by guidance. Past Earnings PerformanceDuring the last quarte…